Public Health and Medical Partnership Signed to Support Suicide Prevention Efforts

Spark BioLab, under the SparkLabs Group, announced on the 26th that it has signed a public health and medical business agreement with Henry Ford Health in the United States to support suicide prevention efforts in South Korea.


Through the agreement, Spark BioLab will develop and establish a standardized response system designed to fill structural gaps in local suicide prevention policies, drawing on the 'Zero Suicide' suicide prevention framework of Henry Ford Health.

Spark BioLab Partners with Henry Ford Health to Build a Suicide Prevention Safety Net View original image

Additionally, the two organizations plan to cooperate on several fronts, including: ▲ building research infrastructure for suicide prevention ▲ exchanges and training programs for professionals such as faculty, researchers, and medical residents ▲ identifying and developing clinical content specialized in suicide prevention ▲ and seeking to establish joint ventures related to domestic suicide prevention.


Henry Ford Health, a healthcare institution headquartered in Detroit, Michigan, has implemented its Zero Suicide model—systematically identifying patients early and providing comprehensive care from treatment to follow-up—since 2001, treating suicide as a preventable issue. The institution succeeded in reducing its internal suicide rate by more than 80%.



A Spark BioLab official stated, "Our goal is to evolve this into a joint initiative with Henry Ford Health that delivers sustainable and measurable value to patients, medical staff, and the community," adding, "We will continue building a meaningful platform that links global healthcare expertise with the medical and bio ecosystem in Korea."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing